Delcath Systems Inc

Research Delcath Systems Inc (DCTH) on Bullrun: market cap USD 447.05M, P/E 2158.3. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerDCTH
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 447.05M
• P/E2158.3
• Financial periodFY2025
• RevenueUSD 85.23M
• Revenue growth129.1%
• Net incomeUSD 2.70M
• Free cash flowUSD 20.97M
• Gross margin86.2%

Valuation Snapshot

latest market cap is USD 447.05M; P/E is 2158.3.

About Delcath Systems Inc

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Frequently asked questions

What is Delcath Systems Inc's market cap?

Delcath Systems Inc's market capitalization is USD 447.05M.

What is Delcath Systems Inc's P/E ratio?

Delcath Systems Inc's price-to-earnings (P/E) ratio is 2158.3.

What does Delcath Systems Inc do?

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.